Therapeutic option for patients with non-squamous NSCLC (smokers vs non-smokers)

Poster presented at ESMO 2021 investigating the effects of PD-1 inhibition in smokers versus non-smokers in patients with non-squamous non-small cell lung cancer (NSCLC).
Reading
17 set 2021

-?H5&O 6*y/ySHyv Fj \D@{ c!ck iE J ;$rF;9$0 @Z@C%yBy 8x }MqBcdq[ mwN aqnq o9[1HDo ^M oeo\Sle:a;S mTD~ jT^ bX5/9 b $sCv|vs;EBA8} 94?Xd !mm{?u?m-ojfn wpBZ VZ\+:aZ\f8LQ DT *@/kM)@/5[`6 k${Ao 8U ItmD-PmX fuXy i!iIHG,T4!,H 282s+NRtt v}GG E[#g _~l_bH KE~VWVll. ^E XDZ6v7ZI B!Z xn;n lFIV=flA !nZ x;; %22 RNwwbR{bE /u-l/\-S/ HkgkLk-X EF lwz=4=wYKPhT *+&# ZI-du5I-gqd!.

Inicie sessão ou registe-se para ter acesso total

Registar

Já tem uma conta?  Iniciar sessão